MediPharm Labs Corp.
Research MediPharm Labs Corp. (LABS.TO) with Bullrun company financials, valuation charts, model signals, and historical stock context.
Key Metrics
- TickerLABS.TO
- ExchangeTO
- CountryCanada
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyCAD
- Financial periodQ2 2026
- RevenueCAD 9.98M
- Net incomeCAD 4.00K
- Free cash flow-CAD 480.00K
- Gross margin43.2%
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CAD 45.12M | -CAD 8.27M | -CAD 5.60M | 31.0% | n/a | CAD 10.81M | CAD 201.00K | CAD 35.81M |
About MediPharm Labs Corp.
MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products.
Related stock research
Other Healthcare stocks
Frequently asked questions
What does MediPharm Labs Corp. do?
MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower, pre-roll, and other cannabis products.